Report Detail

Medical Devices & Consumables Global Diabetes Testing Program Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4618634
  • |
  • 26 September, 2024
  • |
  • Global
  • |
  • 139 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

A Diabetes Testing Program refers to a systematic approach or plan designed to test individuals for diabetes or monitor blood glucose levels in individuals who have already been diagnosed with diabetes.
According to our (Global Info Research) latest study, the global Diabetes Testing Program market size was valued at US$ 2404 million in 2023 and is forecast to a readjusted size of USD 3944 million by 2030 with a CAGR of 7.4% during review period.
The Global key players of Diabetes Testing Program include Roche, LifeScan, Abbott Laboratories, etc. The top three players hold a share over 44%. China is the largest market, and has a share about 33%. In terms of product type, HbA1c Test is the largest segment, which occupied for a share of about 66%. For application, Home Test is the largest segment, which has a share about 42%.
This report is a detailed and comprehensive analysis for global Diabetes Testing Program market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Diabetes Testing Program market size and forecasts, in consumption value ($ Million), 2019-2030
Global Diabetes Testing Program market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Diabetes Testing Program market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Diabetes Testing Program market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Diabetes Testing Program
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Diabetes Testing Program market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, LifeScan, Abbott Laboratories, Ascensia, Arkray, I-SENS, Omron, Braun, Siemens, Bio-Rad Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Diabetes Testing Program market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Diabetes Testing Program market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
HbA1c Test
Finger-prick Test
Market segment by Application
Medical Diagnosis
Home Test
Lab Testing
Market segment by players, this report covers
Roche
LifeScan
Abbott Laboratories
Ascensia
Arkray
I-SENS
Omron
Braun
Siemens
Bio-Rad Laboratories
Tosoh
Danaher Corporation
Trinity Biotech
HUMAN Diagnostics
Terumo
Sinocare
Acon Biotech
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Diabetes Testing Program product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Diabetes Testing Program, with revenue, gross margin, and global market share of Diabetes Testing Program from 2019 to 2024.
Chapter 3, the Diabetes Testing Program competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Diabetes Testing Program market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diabetes Testing Program.
Chapter 13, to describe Diabetes Testing Program research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Diabetes Testing Program by Type
    • 1.3.1 Overview: Global Diabetes Testing Program Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Diabetes Testing Program Consumption Value Market Share by Type in 2023
    • 1.3.3 HbA1c Test
    • 1.3.4 Finger-prick Test
  • 1.4 Global Diabetes Testing Program Market by Application
    • 1.4.1 Overview: Global Diabetes Testing Program Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Medical Diagnosis
    • 1.4.3 Home Test
    • 1.4.4 Lab Testing
  • 1.5 Global Diabetes Testing Program Market Size & Forecast
  • 1.6 Global Diabetes Testing Program Market Size and Forecast by Region
    • 1.6.1 Global Diabetes Testing Program Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Diabetes Testing Program Market Size by Region, (2019-2030)
    • 1.6.3 North America Diabetes Testing Program Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Diabetes Testing Program Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Diabetes Testing Program Market Size and Prospect (2019-2030)
    • 1.6.6 South America Diabetes Testing Program Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Diabetes Testing Program Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Diabetes Testing Program Product and Solutions
    • 2.1.4 Roche Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 LifeScan
    • 2.2.1 LifeScan Details
    • 2.2.2 LifeScan Major Business
    • 2.2.3 LifeScan Diabetes Testing Program Product and Solutions
    • 2.2.4 LifeScan Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 LifeScan Recent Developments and Future Plans
  • 2.3 Abbott Laboratories
    • 2.3.1 Abbott Laboratories Details
    • 2.3.2 Abbott Laboratories Major Business
    • 2.3.3 Abbott Laboratories Diabetes Testing Program Product and Solutions
    • 2.3.4 Abbott Laboratories Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.4 Ascensia
    • 2.4.1 Ascensia Details
    • 2.4.2 Ascensia Major Business
    • 2.4.3 Ascensia Diabetes Testing Program Product and Solutions
    • 2.4.4 Ascensia Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Ascensia Recent Developments and Future Plans
  • 2.5 Arkray
    • 2.5.1 Arkray Details
    • 2.5.2 Arkray Major Business
    • 2.5.3 Arkray Diabetes Testing Program Product and Solutions
    • 2.5.4 Arkray Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Arkray Recent Developments and Future Plans
  • 2.6 I-SENS
    • 2.6.1 I-SENS Details
    • 2.6.2 I-SENS Major Business
    • 2.6.3 I-SENS Diabetes Testing Program Product and Solutions
    • 2.6.4 I-SENS Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 I-SENS Recent Developments and Future Plans
  • 2.7 Omron
    • 2.7.1 Omron Details
    • 2.7.2 Omron Major Business
    • 2.7.3 Omron Diabetes Testing Program Product and Solutions
    • 2.7.4 Omron Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Omron Recent Developments and Future Plans
  • 2.8 Braun
    • 2.8.1 Braun Details
    • 2.8.2 Braun Major Business
    • 2.8.3 Braun Diabetes Testing Program Product and Solutions
    • 2.8.4 Braun Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Braun Recent Developments and Future Plans
  • 2.9 Siemens
    • 2.9.1 Siemens Details
    • 2.9.2 Siemens Major Business
    • 2.9.3 Siemens Diabetes Testing Program Product and Solutions
    • 2.9.4 Siemens Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Siemens Recent Developments and Future Plans
  • 2.10 Bio-Rad Laboratories
    • 2.10.1 Bio-Rad Laboratories Details
    • 2.10.2 Bio-Rad Laboratories Major Business
    • 2.10.3 Bio-Rad Laboratories Diabetes Testing Program Product and Solutions
    • 2.10.4 Bio-Rad Laboratories Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.11 Tosoh
    • 2.11.1 Tosoh Details
    • 2.11.2 Tosoh Major Business
    • 2.11.3 Tosoh Diabetes Testing Program Product and Solutions
    • 2.11.4 Tosoh Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Tosoh Recent Developments and Future Plans
  • 2.12 Danaher Corporation
    • 2.12.1 Danaher Corporation Details
    • 2.12.2 Danaher Corporation Major Business
    • 2.12.3 Danaher Corporation Diabetes Testing Program Product and Solutions
    • 2.12.4 Danaher Corporation Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Danaher Corporation Recent Developments and Future Plans
  • 2.13 Trinity Biotech
    • 2.13.1 Trinity Biotech Details
    • 2.13.2 Trinity Biotech Major Business
    • 2.13.3 Trinity Biotech Diabetes Testing Program Product and Solutions
    • 2.13.4 Trinity Biotech Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Trinity Biotech Recent Developments and Future Plans
  • 2.14 HUMAN Diagnostics
    • 2.14.1 HUMAN Diagnostics Details
    • 2.14.2 HUMAN Diagnostics Major Business
    • 2.14.3 HUMAN Diagnostics Diabetes Testing Program Product and Solutions
    • 2.14.4 HUMAN Diagnostics Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 HUMAN Diagnostics Recent Developments and Future Plans
  • 2.15 Terumo
    • 2.15.1 Terumo Details
    • 2.15.2 Terumo Major Business
    • 2.15.3 Terumo Diabetes Testing Program Product and Solutions
    • 2.15.4 Terumo Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Terumo Recent Developments and Future Plans
  • 2.16 Sinocare
    • 2.16.1 Sinocare Details
    • 2.16.2 Sinocare Major Business
    • 2.16.3 Sinocare Diabetes Testing Program Product and Solutions
    • 2.16.4 Sinocare Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Sinocare Recent Developments and Future Plans
  • 2.17 Acon Biotech
    • 2.17.1 Acon Biotech Details
    • 2.17.2 Acon Biotech Major Business
    • 2.17.3 Acon Biotech Diabetes Testing Program Product and Solutions
    • 2.17.4 Acon Biotech Diabetes Testing Program Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Acon Biotech Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Diabetes Testing Program Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Diabetes Testing Program by Company Revenue
    • 3.2.2 Top 3 Diabetes Testing Program Players Market Share in 2023
    • 3.2.3 Top 6 Diabetes Testing Program Players Market Share in 2023
  • 3.3 Diabetes Testing Program Market: Overall Company Footprint Analysis
    • 3.3.1 Diabetes Testing Program Market: Region Footprint
    • 3.3.2 Diabetes Testing Program Market: Company Product Type Footprint
    • 3.3.3 Diabetes Testing Program Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Diabetes Testing Program Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Diabetes Testing Program Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Diabetes Testing Program Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Diabetes Testing Program Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Diabetes Testing Program Consumption Value by Type (2019-2030)
  • 6.2 North America Diabetes Testing Program Market Size by Application (2019-2030)
  • 6.3 North America Diabetes Testing Program Market Size by Country
    • 6.3.1 North America Diabetes Testing Program Consumption Value by Country (2019-2030)
    • 6.3.2 United States Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Diabetes Testing Program Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Diabetes Testing Program Consumption Value by Type (2019-2030)
  • 7.2 Europe Diabetes Testing Program Consumption Value by Application (2019-2030)
  • 7.3 Europe Diabetes Testing Program Market Size by Country
    • 7.3.1 Europe Diabetes Testing Program Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 7.3.3 France Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Diabetes Testing Program Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Diabetes Testing Program Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Diabetes Testing Program Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Diabetes Testing Program Market Size by Region
    • 8.3.1 Asia-Pacific Diabetes Testing Program Consumption Value by Region (2019-2030)
    • 8.3.2 China Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 8.3.5 India Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Diabetes Testing Program Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Diabetes Testing Program Consumption Value by Type (2019-2030)
  • 9.2 South America Diabetes Testing Program Consumption Value by Application (2019-2030)
  • 9.3 South America Diabetes Testing Program Market Size by Country
    • 9.3.1 South America Diabetes Testing Program Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Diabetes Testing Program Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Diabetes Testing Program Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Diabetes Testing Program Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Diabetes Testing Program Market Size by Country
    • 10.3.1 Middle East & Africa Diabetes Testing Program Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Diabetes Testing Program Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Diabetes Testing Program Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Diabetes Testing Program Market Drivers
  • 11.2 Diabetes Testing Program Market Restraints
  • 11.3 Diabetes Testing Program Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Diabetes Testing Program Industry Chain
  • 12.2 Diabetes Testing Program Upstream Analysis
  • 12.3 Diabetes Testing Program Midstream Analysis
  • 12.4 Diabetes Testing Program Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Diabetes Testing Program. Industry analysis & Market Report on Diabetes Testing Program is a syndicated market report, published as Global Diabetes Testing Program Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Diabetes Testing Program market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,700.48
    4,050.72
    5,400.96
    3,243.36
    4,865.04
    6,486.72
    536,929.20
    805,393.80
    1,073,858.40
    293,433.60
    440,150.40
    586,867.20
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report